"Anemia"

Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease.
BACKGROUND: Bronchodilators are used to treat bronchial hyper-responsiveness in asthma. Bronchial hyper-responsiveness may be a …
Knight-Madden, Jennifer M, Hambleton, Ian R
Cite DOI
Newborn screening for abnormal haemoglobins in Jamaica: Practical issues in an island programme.
OBJECTIVE: To report the diagnostic challenges of newborn screening for abnormal haemoglobins. SETTING: Cord blood samples from 13 …
Serjeant, Graham R, Serjeant, Beryl E, Mason, Karlene P, Gibson, Felicea, Gardner, Ruth-Ann, Warren, Lansford, Hambleton, Ian R, Thein, Swee L, Happich, Margit
Cite DOI
Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
BACKGROUND: Sickle cell disease (SCD) is a group of inherited disorders of haemoglobin (Hb) structure in a person who has inherited two …
Tess E. Cooper, Ian R. Hambleton, Samir K. Ballas, Brydee A. Johnston, Philip J. Wiffen
Cite DOI
Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.
BACKGROUND: Sickle cell disease is a genetic haemoglobin disorder, which can cause severe pain, significant end-organ damage, pulmonary …
Lise J. Estcourt, Sally Hopewell, Marialena Trivella, Ian R. Hambleton, Gavin Cho
Cite DOI
Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth.
Globally, the majority of persons born with sickle cell disease do not have access to hydroxyurea or more expensive interventions. The …
Graham R. Serjeant, Nicki Chin, Monika R. Asnani, Beryl E. Serjeant, Karlene P. Mason, Ian R. Hambleton, Jennifer M. Knight-Madden
Cite DOI
Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.
BACKGROUND: Sickle cell disease is a genetic haemoglobin disorder, which can cause severe pain, significant end-organ damage, pulmonary …
Lise J. Estcourt, Patricia M. Fortin, Sally Hopewell, Marialena Trivella, Ian R. Hambleton, Gavin Cho
Cite DOI
Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease.
Sickle Cell Disease (SCD) is a genetic condition which manifests as altered hemoglobin (Hb) protein that can aggregate under hypoxic …
Kim R. Quimby, Ian R. Hambleton, R. Clive Landis
Cite DOI
Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease.
BACKGROUND: Bronchodilators are used to treat bronchial hyper-responsiveness in asthma. Bronchial hyper-responsiveness may be a …
Jennifer M. Knight-Madden, Ian R. Hambleton
Cite DOI
Clinical findings associated with homozygous sickle cell disease in the Barbadian population--do we need a national SCD registry?
BACKGROUND: Comprehensive care in homozygous sickle cell disease (HbSS) entails universal neonatal screening and subsequent monitoring …
Kim R. Quimby, Stephen Moe, Ian Sealy, Christopher Nicholls, Ian R. Hambleton, R. Clive Landis
Cite DOI
Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.
BACKGROUND: Sickle cell disease can cause severe vaso-occlusive crises and dysfunction of most organ systems. The two most common …
Gavin Cho, Ian R. Hambleton
Cite DOI